Trader Outset Medical, Inc. - OM CFD
Ajouter aux favoris- Résumé
- Données historiques
- Événements
- Compte de résultat
- Bilan
- Flux de trésorerie
- Capital
Conditions de trading
| Écart | 0.07 | ||||||||
|
Frais de position longue en overnight
Long position overnight fee
Aller vers la plateforme | -0.025457% | ||||||||
|
Frais de position courte en overnight
Short position overnight fee
Aller vers la plateforme | 0.003235% | ||||||||
| Durée des frais en overnight | 21:00 (UTC) | ||||||||
| Quantité minimale négociée | 1 | ||||||||
| Devise | USD | ||||||||
| Marge | 20% | ||||||||
| Bourse | United States of America | ||||||||
| Commission sur la négociation | 0% |
*Information provided by Capital.com
Outset Medical Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Chiffres clés
| Fermeture précédente* | 23.05 |
| Ouvert* | 22.9 |
| Variation sur 1 an* | 3.81% |
| Fourchette du jour* | 22.65 - 23.14 |
| Fourchette sur 52 semaines | 11.41-30.55 |
| Volume moyen (10 jours) | 445.98K |
| Volume moyen (3 mois) | 11.04M |
| Capitalisation boursière | 1.14B |
| Ratio C/B | -100.00K |
| Actions en circulation | 49.23M |
| Revenu | 118.29M |
| EPS | -3.51 |
| Dividende (rendement en %) | N/A |
| Bêta | -100.00K |
| Prochaine date de publication des résultats | Jul 31, 2023 |
Toutes les données sont fournies par Refinitiv, à l'exception des données marquées d'un astérisque, qui sont des *données fournies par Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Clôture | Change | Change (%) | Ouverture | High | Low |
|---|---|---|---|---|---|---|
| Jun 9, 2023 | 22.86 | 0.04 | 0.18% | 22.82 | 23.18 | 22.65 |
| Jun 8, 2023 | 23.05 | 0.34 | 1.50% | 22.71 | 23.23 | 22.34 |
| Jun 7, 2023 | 22.89 | 0.02 | 0.09% | 22.87 | 23.68 | 22.66 |
| Jun 6, 2023 | 22.85 | 1.43 | 6.68% | 21.42 | 23.10 | 21.42 |
| Jun 5, 2023 | 21.59 | -0.45 | -2.04% | 22.04 | 22.25 | 21.47 |
| Jun 2, 2023 | 22.28 | 0.48 | 2.20% | 21.80 | 22.42 | 21.49 |
| Jun 1, 2023 | 21.80 | 1.07 | 5.16% | 20.73 | 22.05 | 20.46 |
| May 31, 2023 | 20.83 | -0.22 | -1.05% | 21.05 | 21.21 | 20.24 |
| May 30, 2023 | 21.22 | -0.08 | -0.38% | 21.30 | 21.67 | 20.71 |
| May 26, 2023 | 21.38 | 1.76 | 8.97% | 19.62 | 21.41 | 19.48 |
| May 25, 2023 | 20.20 | 0.23 | 1.15% | 19.97 | 20.26 | 19.47 |
| May 24, 2023 | 20.30 | 0.77 | 3.94% | 19.53 | 20.49 | 19.47 |
| May 23, 2023 | 20.13 | -1.50 | -6.93% | 21.63 | 22.29 | 19.73 |
| May 22, 2023 | 22.06 | 1.31 | 6.31% | 20.75 | 22.32 | 20.74 |
| May 19, 2023 | 21.18 | 0.19 | 0.91% | 20.99 | 21.76 | 20.99 |
| May 18, 2023 | 21.03 | 1.50 | 7.68% | 19.53 | 21.14 | 19.47 |
| May 17, 2023 | 20.08 | 0.10 | 0.50% | 19.98 | 20.22 | 19.51 |
| May 16, 2023 | 20.14 | 0.37 | 1.87% | 19.77 | 20.17 | 19.48 |
| May 15, 2023 | 20.11 | 0.09 | 0.45% | 20.02 | 20.32 | 19.61 |
| May 12, 2023 | 19.98 | 0.01 | 0.05% | 19.97 | 20.28 | 19.62 |
Outset Medical, Inc. Events
| Heure (UTC) (UTC) | Pays | Événement |
|---|---|---|
| Wednesday, June 14, 2023 | ||
| Heure (UTC) (UTC) 15:00 | Pays US
| Événement Outset Medical Inc at Goldman Sachs Healthcare Conference Outset Medical Inc at Goldman Sachs Healthcare ConferenceForecast -Previous - |
| Monday, July 31, 2023 | ||
| Heure (UTC) (UTC) 10:59 | Pays US
| Événement Q2 2023 Outset Medical Inc Earnings Release Q2 2023 Outset Medical Inc Earnings ReleaseForecast -Previous - |
| Monday, November 6, 2023 | ||
| Heure (UTC) (UTC) 10:59 | Pays US
| Événement Q3 2023 Outset Medical Inc Earnings Release Q3 2023 Outset Medical Inc Earnings ReleaseForecast -Previous - |
- Annuel
- Trimestriel
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Revenu total | 115.375 | 102.602 | 49.935 | 15.078 | 2.007 |
| Revenu | 115.375 | 102.602 | 49.935 | 15.078 | 2.007 |
| Coût des recettes, total | 97.542 | 94.994 | 62.972 | 32.88 | 8.122 |
| Résultat brut | 17.833 | 7.608 | -13.037 | -17.802 | -6.115 |
| Total des frais d'exploitation | 277.761 | 233.121 | 168.969 | 85.385 | 48.57 |
| Total des frais de vente/Généraux/Admin | 129.997 | 101.386 | 75.58 | 29.178 | 17.532 |
| Recherche et développement | 48.855 | 36.741 | 28.85 | 23.327 | 22.916 |
| Produits d'exploitation | -162.386 | -130.519 | -119.034 | -70.307 | -46.563 |
| Produits (charges) d'intérêts, nets Hors exploitation | -0.275 | -1.217 | -2.365 | -1.772 | -2.93 |
| Autres, nets | 0 | 0 | -0.093 | 3.8 | -0.262 |
| Résultat net avant impôts | -162.661 | -131.736 | -121.492 | -68.279 | -49.755 |
| Résultat net après impôts | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
| Résultat net avant éléments extra | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
| Résultat net | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
| Total Adjustments to Net Income | 0 | 42.168 | -17.163 | -23.3 | |
| Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
| Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
| Résultat net dilué | -162.956 | -131.935 | -79.324 | -85.462 | -73.08 |
| Moyenne pondérée des actions diluées | 48.161 | 45.589 | 42.722 | 45.2225 | 45.2225 |
| BPA dilué hors éléments extraordinaires | -3.38357 | -2.89401 | -1.85675 | -1.88981 | -1.61601 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
| BPA dilué normalisé | -3.36512 | -2.89401 | -1.82007 | -1.88981 | -1.61601 |
| Charges (revenus) inhabituelles | 1.367 | 0 | 1.567 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Revenu total | 33.467 | 32.007 | 27.761 | 25.057 | 30.55 |
| Revenu | 33.467 | 32.007 | 27.761 | 25.057 | 30.55 |
| Coût des recettes, total | 27.039 | 26.734 | 23.425 | 21.275 | 26.108 |
| Résultat brut | 6.428 | 5.273 | 4.336 | 3.782 | 4.442 |
| Total des frais d'exploitation | 76.952 | 73.198 | 68.76 | 68.778 | 67.025 |
| Total des frais de vente/Généraux/Admin | 36.12 | 33.653 | 32.276 | 33.982 | 30.086 |
| Recherche et développement | 13.793 | 11.444 | 13.059 | 13.521 | 10.831 |
| Produits d'exploitation | -43.485 | -41.191 | -40.999 | -43.721 | -36.475 |
| Produits (charges) d'intérêts, nets Hors exploitation | -0.294 | -0.189 | 0.238 | -0.022 | -0.302 |
| Autres, nets | 0 | ||||
| Résultat net avant impôts | -43.779 | -41.38 | -40.761 | -43.743 | -36.777 |
| Résultat net après impôts | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
| Résultat net avant éléments extra | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
| Résultat net | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
| Total Adjustments to Net Income | |||||
| Revenu disponible pour les actionnaires ordinaires, hors éléments exceptionnels | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
| Bénéfice disponible pour les actionnaires ordinaires, y compris les éléments exceptionnels | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
| Résultat net dilué | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 |
| Moyenne pondérée des actions diluées | 48.783 | 49.139 | 48.129 | 47.882 | 47.487 |
| BPA dilué hors éléments extraordinaires | -0.90136 | -0.8434 | -0.84733 | -0.91556 | -0.77689 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| BPA dilué normalisé | -0.90136 | -0.82532 | -0.84733 | -0.91556 | -0.77689 |
| Charges (revenus) inhabituelles | 1.367 |
- Annuel
- Trimestriel
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total de l'actif à court terme | 373.645 | 409.802 | 345.911 | 79.646 | 147.646 |
| Espèces et placements à court terme | 287.502 | 339.488 | 314.87 | 69.378 | 142.782 |
| Trésorerie et équivalents | 73.222 | 182.348 | 294.972 | 36.226 | 33.264 |
| Investissements à court terme | 214.28 | 157.14 | 19.898 | 33.152 | 109.518 |
| Total des créances, nettes | 28.07 | 25.6 | 6.468 | 3.914 | 1.088 |
| Accounts Receivable - Trade, Net | 28.07 | 25.6 | 6.468 | 3.914 | 1.088 |
| Total Inventory | 51.476 | 39.185 | 18.384 | 4.596 | 3.022 |
| Prepaid Expenses | 6.597 | 5.529 | 6.189 | 1.058 | 0.754 |
| Total Assets | 400.115 | 463.464 | 403.829 | 88.366 | 151.13 |
| Property/Plant/Equipment, Total - Net | 21.993 | 20.195 | 23.251 | 7.895 | 2.926 |
| Property/Plant/Equipment, Total - Gross | 32.8 | 27.849 | 28.239 | 10.565 | 5.149 |
| Accumulated Depreciation, Total | -10.807 | -7.654 | -4.988 | -2.67 | -2.223 |
| Other Long Term Assets, Total | 4.477 | 33.467 | 34.667 | 0.825 | 0.558 |
| Total Current Liabilities | 51.949 | 51.695 | 36.692 | 24.91 | 10.213 |
| Accounts Payable | 0.603 | 1.763 | 4.948 | 4.96 | 3.373 |
| Accrued Expenses | 35.575 | 39.575 | 26.578 | 10.43 | 5.349 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 7.509 | 0.01 | ||
| Other Current Liabilities, Total | 15.771 | 10.357 | 5.166 | 2.011 | 1.481 |
| Total Liabilities | 154.125 | 89.383 | 75.22 | 51.107 | 46.796 |
| Total Long Term Debt | 96.336 | 29.762 | 29.674 | 21.561 | 28.355 |
| Long Term Debt | 96.336 | 29.762 | 29.674 | 21.561 | 28.346 |
| Capital Lease Obligations | 0 | 0.009 | |||
| Other Liabilities, Total | 5.84 | 7.926 | 8.854 | 4.636 | 8.228 |
| Total Equity | 245.99 | 374.081 | 328.609 | 37.259 | 104.334 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 409.446 | 392.284 |
| Common Stock | 0.048 | 0.047 | 0.043 | 0.007 | 0.006 |
| Additional Paid-In Capital | 1035.46 | 1000.21 | 822.624 | 0.356 | 0 |
| Retained Earnings (Accumulated Deficit) | -788.95 | -625.994 | -494.059 | -372.572 | -287.896 |
| Unrealized Gain (Loss) | -0.564 | -0.184 | 0.001 | 0.022 | -0.06 |
| Total Liabilities & Shareholders’ Equity | 400.115 | 463.464 | 403.829 | 88.366 | 151.13 |
| Total Common Shares Outstanding | 48.465 | 47.241 | 42.722 | 45.2225 | 45.2225 |
| Other Current Assets, Total | 0.7 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total de l'actif à court terme | 337.275 | 373.645 | 310.003 | 345.777 | 377.426 |
| Espèces et placements à court terme | 249.213 | 287.502 | 227.517 | 262.062 | 302.267 |
| Trésorerie et équivalents | 36.386 | 73.222 | 63.877 | 75.497 | 114.346 |
| Investissements à court terme | 212.827 | 214.28 | 163.64 | 186.565 | 187.921 |
| Total des créances, nettes | 34.314 | 28.07 | 22.512 | 24.627 | 26.899 |
| Accounts Receivable - Trade, Net | 34.314 | 28.07 | 22.512 | 24.627 | 26.899 |
| Total Inventory | 47.733 | 51.476 | 55.26 | 53.689 | 42.873 |
| Prepaid Expenses | 6.015 | 6.597 | 4.714 | 5.399 | 5.387 |
| Total Assets | 362.665 | 400.115 | 365.722 | 401.236 | 431.742 |
| Property/Plant/Equipment, Total - Net | 21.012 | 21.993 | 22.022 | 21.932 | 20.844 |
| Other Long Term Assets, Total | 4.378 | 4.477 | 33.697 | 33.527 | 33.472 |
| Total Current Liabilities | 44.268 | 51.949 | 49.644 | 55.24 | 48.89 |
| Accounts Payable | 1.988 | 0.603 | 1.444 | 2.753 | 5.149 |
| Accrued Expenses | 27.957 | 35.575 | 34.041 | 36.973 | 30.789 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 14.323 | 15.771 | 14.159 | 14.514 | 12.952 |
| Total Liabilities | 146.379 | 154.125 | 86.619 | 91.472 | 86.289 |
| Total Long Term Debt | 96.48 | 96.336 | 29.828 | 28.806 | 29.784 |
| Long Term Debt | 96.48 | 96.336 | 29.828 | 28.806 | 29.784 |
| Other Liabilities, Total | 5.631 | 5.84 | 7.147 | 7.426 | 7.615 |
| Total Equity | 216.286 | 245.99 | 279.103 | 309.764 | 345.453 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.049 | 0.048 | 0.048 | 0.048 | 0.048 |
| Additional Paid-In Capital | 1049.27 | 1035.46 | 1027.49 | 1017.4 | 1008.94 |
| Retained Earnings (Accumulated Deficit) | -832.921 | -788.95 | -747.506 | -706.725 | -662.886 |
| Unrealized Gain (Loss) | -0.113 | -0.564 | -0.934 | -0.955 | -0.649 |
| Total Liabilities & Shareholders’ Equity | 362.665 | 400.115 | 365.722 | 401.236 | 431.742 |
| Total Common Shares Outstanding | 49.216 | 48.465 | 48.295 | 47.997 | 47.712 |
| Current Port. of LT Debt/Capital Leases | 1 | ||||
| Property/Plant/Equipment, Total - Gross | 32.8 | ||||
| Accumulated Depreciation, Total | -10.807 |
- Annuel
- Trimestriel
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Revenu net/Ligne de départ | -162.956 | -131.935 | -121.492 | -68.299 | -49.78 |
| Liquidités provenant des activités d'exploitation | -145.729 | -130.264 | -99.015 | -70.292 | -46.442 |
| Liquidités provenant des activités d'exploitation | 5.169 | 5.162 | 3.159 | 1.484 | 1.069 |
| Éléments non monétaires | 33.2 | 22.112 | 25.167 | -1.878 | 2.486 |
| Cash Taxes Paid | 0.385 | 0.083 | 0.019 | 0.035 | 0.009 |
| Variation du fonds de roulement | -21.142 | -25.603 | -5.849 | -1.599 | -0.217 |
| Flux de trésorerie liés aux activités d'investissement | -66.295 | -142.507 | 3.947 | 74.297 | -68.776 |
| Dépenses d'investissement | -8.325 | -3.108 | -9.108 | -3.293 | -1.766 |
| Autres éléments de flux de trésorerie d'investissement, total | -57.97 | -139.399 | 13.055 | 77.59 | -67.01 |
| Flux de trésorerie provenant des activités de financement | 72.898 | 160.147 | 385.682 | 0.249 | 134.872 |
| Éléments de flux de trésorerie de financement | -0.181 | 0 | |||
| Émission (remboursement) d'actions, nette | 8.042 | 160.147 | 387.046 | 0.439 | 134.881 |
| Émission (remboursement) de la dette, nette | 64.856 | 0 | -1.364 | -0.009 | -0.009 |
| Variation nette de la trésorerie | -139.126 | -112.624 | 290.614 | 4.254 | 19.654 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -43.971 | -162.956 | -121.512 | -80.731 | -36.892 |
| Cash From Operating Activities | -44.756 | -145.729 | -111.222 | -76.91 | -38.335 |
| Cash From Operating Activities | 1.384 | 5.169 | 3.9 | 2.586 | 1.262 |
| Non-Cash Items | 8.598 | 33.2 | 23.826 | 15.118 | 6.581 |
| Cash Taxes Paid | 0.201 | 0.385 | 0.334 | 0.283 | 0.205 |
| Changes in Working Capital | -10.767 | -21.142 | -17.436 | -13.883 | -9.286 |
| Cash From Investing Activities | 2.643 | -66.295 | -14.547 | -34.706 | -33.39 |
| Capital Expenditures | -0.81 | -8.325 | -6.216 | -3.475 | -1.478 |
| Other Investing Cash Flow Items, Total | 3.453 | -57.97 | -8.331 | -31.231 | -31.912 |
| Cash From Financing Activities | 5.277 | 72.898 | 7.298 | 4.765 | 3.723 |
| Issuance (Retirement) of Stock, Net | 5.277 | 8.042 | 7.433 | 4.765 | 3.723 |
| Issuance (Retirement) of Debt, Net | 64.856 | ||||
| Net Change in Cash | -36.836 | -139.126 | -118.471 | -106.851 | -68.002 |
| Financing Cash Flow Items | -0.135 |
| Nom de l'investisseur | Catégorie de l'investisseur | Pourcentage de l'encours | Actions détenues | Changement d'actions | Date d'avoirs | Taux du chiffre d'affaires |
|---|---|---|---|---|---|---|
| Fidelity Management & Research Company LLC | Investment Advisor | 14.77 | 7270972 | 49376 | 2023-03-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.4572 | 4655616 | 82430 | 2023-03-31 | LOW |
| T. Rowe Price Investment Management, Inc. | Investment Advisor | 6.6916 | 3294148 | -225722 | 2023-03-31 | MED |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.2155 | 3059782 | -77314 | 2023-03-31 | LOW |
| Bellevue Asset Management AG | Investment Advisor | 5.9047 | 2906759 | 63080 | 2023-03-31 | LOW |
| JP Morgan Asset Management | Investment Advisor | 5.5577 | 2735954 | 169738 | 2023-03-31 | LOW |
| JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 3.8619 | 1901126 | 91339 | 2023-03-31 | LOW |
| Champlain Investment Partners, LLC | Investment Advisor | 3.7109 | 1826825 | -33580 | 2023-03-31 | LOW |
| Braidwell LP | Hedge Fund | 3.5637 | 1754350 | 49798 | 2023-03-31 | HIGH |
| Mubadala Investment Company PJSC | Sovereign Wealth Fund | 2.9346 | 1444665 | -1445678 | 2021-12-07 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.6458 | 1302457 | 129782 | 2023-03-31 | LOW |
| Eagle Health Investments LP | Hedge Fund | 2.4384 | 1200385 | -20224 | 2023-03-31 | MED |
| Perceptive Advisors LLC | Private Equity | 2.213 | 1089427 | 0 | 2023-03-31 | MED |
| C WorldWide Asset Management Fondsmaeglerselskab A/S | Investment Advisor | 2.0314 | 1000000 | 0 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8701 | 920601 | 35123 | 2023-03-31 | LOW |
| Pura Vida Investments, LLC | Hedge Fund | 1.8671 | 919136 | 464746 | 2023-03-31 | HIGH |
| RTW Investments L.P. | Investment Advisor/Hedge Fund | 1.6427 | 808658 | -100994 | 2023-03-31 | |
| Columbia Wanger Asset Management, LLC | Investment Advisor | 1.4124 | 695303 | 157420 | 2023-03-31 | MED |
| Jennison Associates LLC | Investment Advisor/Hedge Fund | 1.2327 | 606819 | -3405 | 2023-03-31 | LOW |
| Mellon Investments Corporation | Investment Advisor/Hedge Fund | 1.1932 | 587411 | -16224 | 2023-03-31 | LOW |
Pourquoi choisir capital.com? Nos chiffres parlent d'eux-mêmes.
Capital.com Group535K+
Tradeurs
87K+
Clients actifs par mois
$113M+
Volume d'investissement par mois
$64M+
Retrait par mois
Trading calculator
Calculez votre P&L hypothétique si vous aviez ouvert une transaction CFD à une certaine date (sélectionnez une date) et l'aviez fermée à une autre date (sélectionnez une date).
Trade commission
0
- 1:1
Effet de levier
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Ouverture
Clôture
Short Long
Outset Medical, Inc. Company profile
À propos de Outset Medical, Inc.
Outset Medical, Inc. est une société de technologie médicale qui propose Tablo. Tablo est une solution d'hémodialyse intégrée mobile pour les traitements d'hémodialyse aigus et à domicile. L'intégration de la purification de l'eau et de la production de dialysat à la demande permet à Tablo de servir de clinique de dialyse sur roues et permet aux prestataires d'accéder à une plateforme unique de l'hôpital au domicile. La cartouche Tablo est un consommable à usage unique destiné à faciliter l'épuration extracorporelle du sang des patients et se compose d'une tubulure de sang, de solution saline et de perfusion préconfigurée. L'écran tactile de Tablo permet à l'utilisateur de naviguer dans le traitement grâce à des animations et un langage non technique, adaptés aux utilisateurs professionnels et non professionnels. Le logiciel de connectivité en nuage de Tablo permet un écosystème de diagnostics et d'analyses de la machine, d'instructions de traitement, de surveillance et de rapports, de documentation améliorée et de gestion à distance de la machine. En outre, Tablo fournit également des soins cliniques robustes.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
3052 Orchard Drive
SAN JOSE
CALIFORNIA 95134
US
Compte de résultat
- Annual
- Quarterly
Les gens regardent aussi
Êtes-vous toujours à la recherche d'un broker de confiance?
Rejoignez les plus de 535 000 traders du monde entier qui ont choisi de trader avec Capital.com